Eli Lilly Statistics
Total Valuation
Eli Lilly has a market cap or net worth of $784.02 billion. The enterprise value is $799.01 billion.
Important Dates
The last earnings date was Thursday, February 6, 2025, before market open.
Earnings Date | Feb 6, 2025 |
Ex-Dividend Date | Feb 14, 2025 |
Share Statistics
Eli Lilly has 900.43 million shares outstanding. The number of shares has increased by 0.09% in one year.
Current Share Class | 900.43M |
Shares Outstanding | 900.43M |
Shares Change (YoY) | +0.09% |
Shares Change (QoQ) | -0.20% |
Owned by Insiders (%) | 0.14% |
Owned by Institutions (%) | 87.54% |
Float | 898.28M |
Valuation Ratios
The trailing PE ratio is 74.36 and the forward PE ratio is 37.67. Eli Lilly's PEG ratio is 1.11.
PE Ratio | 74.36 |
Forward PE | 37.67 |
PS Ratio | 17.20 |
Forward PS | 12.91 |
PB Ratio | 54.17 |
P/TBV Ratio | 399.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.11 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 75.45 |
EV / Sales | 17.74 |
EV / EBITDA | 42.62 |
EV / EBIT | 46.89 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 2.18 |
Debt / EBITDA | 1.67 |
Debt / FCF | n/a |
Interest Coverage | 28.15 |
Financial Efficiency
Return on equity (ROE) is 84.10% and return on invested capital (ROIC) is 25.70%.
Return on Equity (ROE) | 84.10% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 25.70% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $1.05M |
Profits Per Employee | $246,279 |
Employee Count | 43,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Eli Lilly has paid $2.09 billion in taxes.
Income Tax | 2.09B |
Effective Tax Rate | 16.49% |
Stock Price Statistics
The stock price has increased by +11.40% in the last 52 weeks. The beta is 0.41, so Eli Lilly's price volatility has been lower than the market average.
Beta (5Y) | 0.41 |
52-Week Price Change | +11.40% |
50-Day Moving Average | 800.45 |
200-Day Moving Average | 847.10 |
Relative Strength Index (RSI) | 63.03 |
Average Volume (20 Days) | 3,365,736 |
Short Selling Information
The latest short interest is 6.77 million, so 0.75% of the outstanding shares have been sold short.
Short Interest | 6.77M |
Short Previous Month | 6.10M |
Short % of Shares Out | 0.75% |
Short % of Float | 0.75% |
Short Ratio (days to cover) | 1.79 |
Income Statement
In the last 12 months, Eli Lilly had revenue of $45.04 billion and earned $10.59 billion in profits. Earnings per share was $11.71.
Revenue | 45.04B |
Gross Profit | 36.62B |
Operating Income | 17.04B |
Pretax Income | 8.99B |
Net Income | 10.59B |
EBITDA | 18.75B |
EBIT | 17.04B |
Earnings Per Share (EPS) | $11.71 |
Full Income Statement Balance Sheet
The company has $3.52 billion in cash and $31.23 billion in debt, giving a net cash position of -$27.16 billion or -$30.16 per share.
Cash & Cash Equivalents | 3.52B |
Total Debt | 31.23B |
Net Cash | -27.16B |
Net Cash Per Share | -$30.16 |
Equity (Book Value) | 14.32B |
Book Value Per Share | 15.82 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 81.31%, with operating and profit margins of 37.83% and 23.51%.
Gross Margin | 81.31% |
Operating Margin | 37.83% |
Pretax Margin | 28.15% |
Profit Margin | 23.51% |
EBITDA Margin | 41.63% |
EBIT Margin | 37.83% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $6.00, which amounts to a dividend yield of 0.69%.
Dividend Per Share | $6.00 |
Dividend Yield | 0.69% |
Dividend Growth (YoY) | 15.14% |
Years of Dividend Growth | 10 |
Payout Ratio | 51.24% |
Buyback Yield | -0.09% |
Shareholder Yield | 0.61% |
Earnings Yield | 1.37% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for Eli Lilly is $985.00, which is 13.13% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $985.00 |
Price Target Difference | 13.13% |
Analyst Consensus | Strong Buy |
Analyst Count | 21 |
Revenue Growth Forecast (5Y) | 17.41% |
EPS Growth Forecast (5Y) | 32.30% |
Stock Forecasts Stock Splits
The last stock split was on October 16, 1997. It was a forward split with a ratio of 2:1.
Last Split Date | Oct 16, 1997 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |